Biomx Ltd (PHGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,856 | -17,327 | -26,169 | -20,678 | -12,772 |
| Depreciation Amortization | 560 | 229 | 1,438 | 1,112 | 771 |
| Accounts payable and accrued liabilities | -5,150 | -1,897 | 1,750 | 3,595 | 2,591 |
| Other Working Capital | -5,038 | -2,719 | 2,476 | 4,214 | 2,611 |
| Other Operating Activity | -109 | 10,358 | -781 | -3,287 | -2,323 |
| Operating Cash Flow | $-22,593 | $-11,356 | $-21,286 | $-15,044 | $-9,122 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 2,000 | 2,000 | 2,000 |
| PPE Investments | 54 | N/A | -49 | -43 | -11 |
| Net Acquisitions | 663 | 663 | N/A | N/A | N/A |
| Investing Cash Flow | $717 | $663 | $1,951 | $1,957 | $1,989 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -10,747 | -10,747 | -4,253 | -2,929 | -1,654 |
| Common Stock Issued | 28,770 | 28,769 | 7,152 | 7,485 | 7,485 |
| Other Financing Activity | 20,749 | 20,953 | 0 | -333 | -301 |
| Financing Cash Flow | $38,772 | $38,975 | $2,899 | $4,223 | $5,530 |
| Exchange Rate Effect | -46 | -31 | 6 | -37 | -29 |
| Beginning Cash Position | 15,864 | 15,864 | 32,294 | 32,294 | 32,294 |
| End Cash Position | 32,714 | 44,115 | 15,864 | 23,393 | 30,662 |
| Net Cash Flow | $16,850 | $28,251 | $-16,436 | $-8,901 | $-1,632 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,593 | -11,356 | -21,286 | -15,044 | -9,122 |
| Capital Expenditure | -9 | N/A | -50 | -43 | -11 |
| Free Cash Flow | -22,602 | -11,356 | -21,336 | -15,087 | -9,133 |